Frontiers
US$ 23.20
how many people are on glp-1 drugs Products - Data Briefs - Number 537 GLP-1 Drugs Show Potential To
Description
Data availability All data generated or analysed during this study are included in this published article and its supplementary information files
Participants were randomly assigned to either placebo or dulaglutide in combination with varenicline and behavioural counselling as part of a 12-week intervention period, with follow-up visits at weeks 24 and 52 [27]
doi: 10.1007/s11011-014-9591-7 180 ShelineY
doi: 10.1016/j.amjmed.2023.07.016 [DOI] [PubMed] [Google Scholar] 176.United State Food and Drug Administration
10.1016/j.psyneuen.2020.104687 76 VestlundJ.JerlhagE
